RecruitingNCT06847282
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Sponsor
University of Kansas Medical Center
Enrollment
80 participants
Start Date
May 22, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The primary goal of this study is to validate motor and functional outcomes and refine clinical trial strategies for pediatric-onset FSHD
Eligibility
Min Age: 5 YearsMax Age: 17 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with muscular dystrophy, facioscapulohumeral. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 5 Years to 17 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06847282
Related Trials
Clenbuterol to Target DUX4 in FSHD
NCT067212993 locations
BetterLife FSHD: A Patient-driven Health and Research Platform
NCT074091421 location
Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
NCT062271821 location
Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy
NCT065174981 location